4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells MXXGeY5kfGmxbjDhd5NigQ>? NHHWdGNC\2:waYP0bYMh[WO2aY\peJkhf2G|IHTleIVzdWmwZXSgbY4hS0:VMTDj[YxteyC2cnHud4Zm[3SnZDD3bZRpKEeDTDC0MXBRSVJiZ3HtcYEhemWlZYD0c5ItKEWFNUC9NE4xOjFizszN MnzpNVI3OTd7MkS=
CV-1 cells NXvDNpZyTnWwY4Tpc44h[XO|YYm= M1fuO21igGmvYXygdoVxd3K2ZYKgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSZYLvfIl{d22nIIDyc4xq\mW{YYTvdkBi[3SrdnH0[YQhemWlZYD0c5Ih\2GvbXGgS4FtPCClaHnt[ZJq[yCrbjD0doFve2mnboTsfUB1emGwc3\lZ5Rm\CCFVj2xJINmdGy|IHL5JIZ2dmO2aX;uZYwh[XO|YYmsJGVEPTB;MD6wOFMh|ryP MnyyNVE4OjB6NUS=
COS-1 cells Mnf2SpVv[3Srb36gZZN{[Xl? M1H3NWlvKH[rdILvJJRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDw[ZJwgGm|b33lJJBzd2yrZnXyZZRweiCjY4TpeoF1\WRicnXj[ZB1d3JiZ3HtcYEhdWWjc4Xy[YQhcW5iUGDBVk1ISUx2IHPobY1memmlIFPPV{0yKGOnbHzzMEBGSzVyPUCuNFIh|ryP NX65RVRnOTJ6N{O1NVc>
CV-1 cells Mn\NSpVv[3Srb36gZZN{[Xl? MofzRYN1cX[jdHnvckBw\iCyZYLvfIl{d22nIIDyc4xq\mW{YYTvdkBi[3SrdnH0[YQhemWlZYD0c5Ih\2GvbXGgcYVie3W{ZXSgZpkhcW6mdXP0bY9vKG:oIEWwKUBw\iCvYYjpcZVuKGGua3HsbY5mKHCqb4PwbIF1[XOnIHHjeIl3cXS7LDD0doFve2[nY4Tpc44h[XO|YYmgbY4hS1ZvMTDj[YxteyxiRVO1NF0xNjB6OUGzJO69VQ>? NFvNNpk6QDN4NkKw
CV-1 cells MVjGeY5kfGmxbjDhd5NigQ>? NF;LT41KdiC4aYTyc{B1emGwc3PybZB1cW:wYXygZYN1cX[jdHnvckBw\iCSZYLvfIl{d22nIIDyc4xq\mW{YYTvdkBi[3SrdnH0[YQhemWlZYD0c5Ih\2GvbXGgLHBRSVJrIHX4dJJme3OnZDDpckBEXi1zIHPlcIx{NCCHQ{WwQVAvODZizszN NVvPO5Y6QDV5NkmwOy=>
COS-1 cells M{n4PWZ2dmO2aX;uJIF{e2G7 NYTWZ2Q{UW5idnn0do8h[WexbnnzeEBi[3Srdnn0fUB1\XO2ZXSg[o9zKHS{YX7zZYN1cX[jdHnvckBqdiCqdX3hckBRWEGUIHfhcY1iNUejbESgZ4hqdWW{aXOgR29UNTFiY3XscJMtKEWFNUC9NE4xOiEQvF2= MY[xNlczQTZ4OB?=
CV-1 cells NHzqOIdHfW6ldHnvckBie3OjeR?= MYHJckB3cXS{bzDleoFtfWG2aX;uJIFo[Wmwc4SgVnhTNWGucHjhM3BRSVJvZ3HtcYEhcW5iQ2[tNUBk\WyuczDifUBkd3S{YX7z[oVkfGmxbjDhd5NigSC5YYOg[IV1\XKvaX7l[EwhTUN3ME2wMlMzPSEQvF2= NIDX[|cyOjl3NEC2NS=>
HepG2 cells NVi2VHc4TnWwY4Tpc44h[XO|YYm= MYfF[oZm[3SrdnWgZ49v[2WwdILheIlwdiCjZ3HpcpN1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSHXwS|Ih[2WubIOsJGVEPTB;MD6wN|kh|ryP MlroNVYyODdzNUC=
Huh7 cells MkPISpVv[3Srb36gZZN{[Xl? NGX5VY9HfW6ldHnvcoFtKGGldHn2bZR6KGG2IHj1cYFvKFCSQWKg[4FudWFiaX6gTJVpPyClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6yNkDPxE1? MojHNVY{PjZ4MEG=
Huh7 cells M{fCWGZ2dmO2aX;uJIF{e2G7 MYDF[oZm[3Rib36gVHBCWiCpYX3tZUB1emGwc3HjeIl3[XSrb36gZYN1cX[rdImgbY4hUHWqNzDj[YxteyxiRVO1NF0xNjJ{IN88US=> NXPMRYhQOTZ2NUGwPFc>
U2OS cells Mlr1SpVv[3Srb36gZZN{[Xl? M1nmR2Vn\mWldDDvckBRWEGUZ3HtcYEhfHKjboPhZ5RqfmG2aX;uJIFkfGm4aYT5JIlvKFV{T2OgZ4VtdHNuIFXDOVA:OC5yMzFOwG0> MnXvNVY{ODB7NES=
CV1 cells MXXGeY5kfGmxbjDhd5NigQ>? MlX4WJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNuIFXDOVA:OC5yN{[g{txO NVrMTVg5OTZ6MkG3Olk>
human keratinocytes MVXQdo9tcW[ncnH0bY9vKGG|c3H5 NF7IdIFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIHvldoF1cW6xY4n0[ZMtKEWFNUC9PEDPxE1? MXOxOlgzOTd4OR?=
HT29 cell NIXQdXlRem:uaX\ldoF1cW:wIHHzd4F6 NIDlW4pCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUNlkh[2WubDDsbY5mNCCHQ{WwQVQ2KM7:TR?= M4XUOVE3QDJzN{[5
NIH3T3 cells M1XmcmZ2dmO2aX;uJIF{e2G7 MXPBZ5Rqfmm2eTDheEBpfW2jbjDQVGFTKGejbX3hJJRz[W6|ZnXjeIVlKGmwIF7JTFNVOyClZXzsd{BjgSCudXPp[oVz[XOnIHHjeIl3cXS7IHHzd4F6NCCHQ{WwQVAvOzJizszN MkfLNVY5PTRyOEW=
CV1 cells NV33[XMyTnWwY4Tpc44h[XO|YYm= M2rwNXRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDQVGFT\2GvbXGgbY4hS1ZzIHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlMxQCEQvF2= Mnn1NVY6PzB|OUG=
Huh7 cells M330WGZ2dmO2aX;uJIF{e2G7 M3qweGFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> MkTPNVcxOzRzNEm=
HepG2 cells MoTKSpVv[3Srb36gZZN{[Xl? NVPkdphISWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUIHfhcY1iKGmwIHGgTIVxTzJiY3XscJMh[nliUGDBVk1ISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlE2QCEQvF2= MWCxOlk4OzN3OB?=
HepG2 cells MWfGeY5kfGmxbjDhd5NigQ>? M17NN2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWiCpYX3tZUBqdiCKZYDHNkBk\WyuczDifUBRWEGULVfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMUW4{txO NGTDelMyPjl5OUO0NS=>
CV1 cells NVzpelFWTnWwY4Tpc44h[XO|YYm= NGPuRVdC[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|LDDFR|UxRTBwM{C4JO69VQ>? NV;GVHRiOTdyMEWzPVQ>
HEK293 cells M{DxZmZ2dmO2aX;uJIF{e2G7 MVPBZ5Rqfmm2eTDheEBpfW2jbjDh[Ilxd3OnIITpd5N2\SCSUFHSJIdidW2jIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYomgVHBCWi2JQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNzIN88US=> M3T3S|E4OzR|M{ex
rat L6 cells NEnk[4lHfW6ldHnvckBie3OjeR?= MXLF[oZm[3Rib36g[oF1fHliYXPp[EBwgGmmYYTpc44hcW5icnH0JGw3KGOnbHzzMEBGSzVyPUWg{txO NEfzPYcyPzN2M{O3NS=>
HepG2 cells Mlq4SpVv[3Srb36gZZN{[Xl? M3P4RmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIlvKEincFeyJINmdGy|IHL5JHBRSVJvR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yOEKg{txO MXmxO|E2PzBzOR?=
CV1 cells MlTWSpVv[3Srb36gZZN{[Xl? NW\pVGlWSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhcW5iQ2[xJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5JIFnfGW{IEK0JIhzeyxiRVO1NF0{NjR4IN88US=> NIHFcXYyPzVyN{KyOS=>
CV1 cells NUTX[IVITnWwY4Tpc44h[XO|YYm= NXiwcGRDSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5JIFnfGW{IEK0JIhzeyxiRVO1NF0xNjB|IN88US=> MY[xO|UxPzJ{NR?=
CV1 cells M1LTUGZ2dmO2aX;uJIF{e2G7 NUfM[pd4SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFPWNUBk\WyuczDifUBz\WOncITvdkB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5|MEig{txO NH;ONIIyQDB{OUG3PC=>
CV1 cells M3;re2Z2dmO2aX;uJIF{e2G7 M1X6XGFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIFPWNUBk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5|MEig{txO NH;ZWHIyPzF{OUeyOS=>
HEK293 cells NVfFTGk3TnWwY4Tpc44h[XO|YYm= MYTB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBz\WOncITvdkBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODN3IN88US=> NV;uUpJROTd{OUK2NFY>
NIH3T3 cells NISxeYhHfW6ldHnvckBie3OjeR?= MmPIRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKE6LSEPUN{Bk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlMzKM7:TR?= MVyxO|YzPDd5Nx?=
HEK293 cells NYfuV2VGTnWwY4Tpc44h[XO|YYm= NXzVeYxISWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG5JO69VQ>? Mk\BNVgxOjlzN{[=
HEK293 cells NFfoWpBHfW6ldHnvckBie3OjeR?= MlWwRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bie3Onc4Pl[EBieyCjUEKg[4Vv\SCrbnT1Z5Rqd25uIFXDOVA:OC5zMjFOwG0> Mn;QNVgxOjlzN{[=
HEK293 cells MYnGeY5kfGmxbjDhd5NigQ>? MonERYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iSFXLNlk{KGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODR3IN88US=> MY[xPFI6OTZ2NR?=
HepG2 cells M{PaeWZ2dmO2aX;uJIF{e2G7 Mmm3RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT[WyyaHGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODN7IN88US=> MXOxPFg{PTdzOR?=
RAW264.7 cells NXziTpNrTnWwY4Tpc44h[XO|YYm= NV;teFBnW3WycILld5Nqd25ib3[gUHBUN0mITj3nZY1u[S2|dHnteYxifGWmIF7PJJBzd2S3Y4Tpc44hcW5ibX;1d4UhWkGZMk[0Mlch[2WubIOsJGVEPTB;MUeuOUDPxE1? Mnf5NVg5ODl|MkW=
BL21 cells MXrGeY5kfGmxbjDhd5NigQ>? MUTEbZNxdGGlZX3lcpQhd2ZicnHkbY8hdGGkZXzl[EAzMFNrLTiyMYJmdnqxeXytdIhmdnmuYX3pco8qNTNve{StX|EtOS2maYTybZRqdy1{LTi1MY1mfGi7bD2yMZBp\W67bD3vfIF7d2xvND35cEku\XSqb4j5YU1xcGWweXz9MZBzd3Crb37pZ{Bi[2mmIH\yc40hT1OWLX\1d4VlKGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iRYPjbIVzcWOqaXGgZ49tcSCETEKxJINmdGy|IHL5JJNkcW62aXzsZZRqd25icILvfIlucXS7IHHzd4F6NCCHQ{WwQVAvPDVizszN NU\GdHVDOTl|NEmxO|Y>
BHK21 cells NIThO|VHfW6ldHnvckBie3OjeR?= MYXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hSkiNMkGgZ4VtdHNiYYPz[ZN{\WRiYYOgV2VCWCCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjR3IN88US=> NYP1XGt1OTl|NEmxO|Y>
HepG2/C3A cells MWfGeY5kfGmxbjDhd5NigQ>? MnXtRYN1cX[jdHnvckBw\iCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwLX3l[IlifGWmIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCKZYDHNk9EO0FiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVzCSEBjgSClb4TyZY5{\mWldHnvckBie3OjeTygSWM2OD1yLkCwN|gh|ryP NXPx[opDOTd2MEO2PFg>
HepG2 cells MWPGeY5kfGmxbjDhd5NigQ>? M{ez[2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZicnXj[ZB1d3JidILhcpNi[3SrdnH0bY9vKGK7IILldI9zfGW{IHflcoUh[XO|YYmgdoVt[XSrdnWgeI8h[2:wdILvcEwhTUN3ME2wMlA2KM7:TR?= MkHONVg3OjV3NUm=
COS1 cells MUjGeY5kfGmxbjDhd5NigQ>? NIXkWVBC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJJJm[2:vYnnuZY51KFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gR29UOSClZXzsd{Bkdy2neIDy[ZN{cW6pIFfBUFQh[XO|ZYPz[YQh[XNidILhcpNkemmydHnvcoFtKGGldHn2bZR6KGGodHXyJFQ5KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yMjFOwG0> MlnnNVk2ODd6NkG=
HepG2 cells M2TrfWZ2dmO2aX;uJIF{e2G7 NX\xNY1OSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOjJ|IN88US=> NVjzVHp[OTh|OUS5NFc>
CV1 cells NGnn[VJHfW6ldHnvckBie3OjeR?= M33RcWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiZoXz[YQhT2GuND3ERmQh[nlidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFM{KM7:TR?= M1\sTFE5QDJ4MkC1
CV1 cells MoO3SpVv[3Srb36gZZN{[Xl? MmO0RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT[WyyaHGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDh[pJq[2GwIHfy[YVvKG2xbnvlfUBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVTCSEBjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;Mz60OkDPxE1? M3zGUFE5QDJ4MkC1
U2OS cells NE[xdIxHfW6ldHnvckBie3OjeR?= Mn\sRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hXTKRUzDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOiEQvF2= MXuxPFMzQTd3MR?=
Hep G2 cells M{fXPGZ2dmO2aX;uJIF{e2G7 M1fZTGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwJGczKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT2GuND3ERmQh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFQh|ryP Ml[yNVkxPTN5N{[=
HeLa cells MULGeY5kfGmxbjDhd5NigQ>? M3XBZmFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVN[SClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbEStSGJFKGG|c3Xzd4VlKGG|IITyZY5{[3KrcITpc45idCCjY4TpeoF1cW:wIHL5JGdidDRicnXzdI9ve2ViZXzlcYVvfC2mcnn2[Y4hdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEG1JO69VQ>? Ml3NNVkzPzV7NkO=
COS1 cells NX3nSldTTnWwY4Tpc44h[XO|YYm= M3rPOGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3MyKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIgh\nW|ZXSgfYVie3RiR3HsOE1FSkRiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODJizszN M4Lt[VE6PTNyNkix
U2OS cells NHTBZ2hHfW6ldHnvckBie3OjeR?= MXHB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hXTKRUzDj[YxteyCkeTDseYNq\mW{YYPlJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB3IN88US=> NVXZbGE{OTl3N{SwOVY>
HepG2 cells Mn;nSpVv[3Srb36gZZN{[Xl? NEX0emtC\2:waYP0JIFkfGm4aYT5JIF1KEeDTESteIFo\2WmIHj1cYFvKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGG|c3Xzd4VlKGG|IILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOzlizszN M4rT[VE6Pzd3MU[5
HepG2 cells M4e4NmZ2dmO2aX;uJIF{e2G7 M4j3XWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKZYDHNkBk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlIzOyEQvF2= NUm2[JhZOTl5OEO0OFQ>
COS7 cells MWPGeY5kfGmxbjDhd5NigQ>? NHvHPI1C\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJJJm[2:vYnnuZY51KFCSQWLnZY1u[TJiTFLEJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3M4KGOnbHzzJINw\XiycnXzd4lv\yCJQVy0JIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5zIN88US=> NFG0coUzODF|OEe2Ni=>
COS7 cells NXzJeIVuTnWwY4Tpc44h[XO|YYm= M4OzUmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWFCDUnfhcY1iOSCOQlSg[ZhxemW|c3XkJIlvKGGocnnjZY4h\3KnZX6gcY9vc2W7IFPPV|ch[2WubIOgZ49mgHC{ZYPzbY5oKEeDTESgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB|IN88US=> MmLHNlAyOzh5NkK=
HEK cells MkXmSpVv[3Srb36gZZN{[Xl? M13PW2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gS2FNPC22YXfn[YQhWFCDUnHsdIhiKGOqaX3ldolkKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWsh[2WubIOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTFyLkW4JO69VQ>? NW\xbnNQOjB{OUmyNVQ>
HEK cells M4L2d2Z2dmO2aX;uJIF{e2G7 NX3H[XJwSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LYTh[4dm\CCSUFHS[4FudWFiY3jpcYVzcWNicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUyClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wN|Uh|ryP MYCyNFI6QTJzNB?=
3T3L1 cells NUHDe3ZsTnWwY4Tpc44h[XO|YYm= M1X5Nlch\GG7cx?= MYTJcoR2[3Srb36gc4Yh[WSrcH;n[Y5me2m|IHnuJI1wfXOnIEPUN2wyKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHzpdIllKGGlY4XteYxifGmxbjDh[pRmeiB5IHThfZMh[nliT3nsJJJm\CCRIIP0ZYlvcW6p NFrFNWwzODV{N{m2PS=>
CHO-K1 cells M{\KfmZ2dmO2aX;uJIF{e2G7 MlzqVIFzfGmjbDDh[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYT3MRmQh\XiycnXzd4VlKGmwIFPIU{1MOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEeDTESgZZN{\XO|ZXSgZZMhdHWlaX\ldoF{\SCjY4Tpeol1gSCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4yKM7:TR?= NXHYPHN1OjB3Mke5Olk>
HEK293T cells MnyxSpVv[3Srb36gZZN{[Xl? NYj1V4hrOSEQvF2= NHXqd|UzPCCqcoO= NF:weVRR[XK2aXHsJIFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hMWxDTCCneIDy[ZN{\WRiaX6gTGVMOjl|VDDj[YxteyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFidV2gZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> MX6yNVA{ODJ4Mx?=
CV1 cells MYnGeY5kfGmxbjDhd5NigQ>? NX3wXVB7XHKjboPhZ5RqfmG2aX;uJI9nKEejbESt[pV{\WRiaIXtZY4hWFCDUnfhcY1iKESQQTDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlEh|ryP MVmyNVEyOjd6NB?=
HEK293 cells MX3GeY5kfGmxbjDhd5NigQ>? M2fPd|E3KHSxIEKwJIhzew>? MkLpWJJidnOjY4TpeoF1cW:wIH;mJGdidDRvZoXz[YQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZYZ1\XJiMU[geI8hOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC0N{DPxE1? M1vqN|IyOTJ6NkCw
HepG2 cells M1W3dmZ2dmO2aX;uJIF{e2G7 NEm4PFcyOCC3bX;sM2w> NW[zXXBUOjRiaILz MlXDTY5kemWjc3WgbY4h\2y3Y3;z[UBkd26|dX3weIlwdiCrbjDoeY1idiCKZYDHNkBk\WyuczDheEAyOCC3bX;sM2wh[W[2ZYKgNlQhcHK|IILlcIF1cX[nIITvJINwdnS{b3y= NV;JcndbOjF{NU[3OFg>
3T3L1 cell NGLqV4pHfW6ldHnvckBie3OjeR?= NF3ibZkyKHWP M2rMNGlv\HWldHnvckBw\iCvb4Xz[UA{XDOOMTDj[YxtKGSrZn\ldoVvfGmjdHnvckBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDhZ4N2dXWuYYTpc44hd2ZiaX70doFk\WyudXzhdkBtcXCrZDDkdo9xdGW2IHH0JFEhfU1iYomgU4ltKHKnZDDPJJN1[WmwaX7n NX72[mpQOjF2MEGxNVg>
CV1 cells MnHtSpVv[3Srb36gZZN{[Xl? M2jGNlQxKGh? NVfFdXVJSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEuVEKGIHX4dJJme3OnZDDpckBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCJYXy0JIFnfGW{IESwJIhzeyCkeTDseYNq\mW{YYPlJIJie2WmIITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlEh|ryP M4jObVIyPTF3ME[z
HepG2 cells NYHJOVlFTnWwY4Tpc44h[XO|YYm= M4\2cWFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKHKnY3XweI9zKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUBRWFKHLXz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlAyKM7:TR?= Mki2NlE1QDJ2NE[=
HepG2 cells NX;wW2wxTnWwY4Tpc44h[XO|YYm= M1\nOnRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiUGDSSVMuXEtvTIXjJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC1JO69VQ>? NH\IOpozOTR3MES2PC=>
COS7 cells NYHrbFZrTnWwY4Tpc44h[XO|YYm= M2P4[m1w\HWuYYTpc44hd2ZiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TO{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkh[nlibIXjbYZmemG|ZTDhd5NigSxiRVO1NF0xNjB2MzFOwG0> NUTlUoZGOjF6N{OwO|A>
COS-1 cells M4jZbmZ2dmO2aX;uJIF{e2G7 NHXsNHQzPCCqcoO= NXPOVZNpSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBEV1NvMTDj[YxteyCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lMYJie2WmIHz1cYlvd22ndILpZ{BidmGueYPpd{whTUN3ME2wMlA1QCEQvF2= MkPHNlIxPTFyNUS=
COS1 cells NWDhOGtwTnWwY4Tpc44h[XO|YYm= MmjGNlQhcHK| M4\2ZnRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDmeYxtKGynbnf0bEBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFPPV|Eh[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBTYFKjbIDoZUBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOTJizszN NYHF[3UzOjJzOUezPVY>
MG-63 cells MnjVSpVv[3Srb36gZZN{[Xl? MYLB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hVUdvNkOgZ4VtdHNiYomgdoVxd3K2ZYKg[4Vv\S2kYYPl[EB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMUGg{txO M1jqbFIzOjJ3NkSx
COS1 cells MX;GeY5kfGmxbjDhd5NigQ>? MYTCbY5lcW6pIHHm[olvcXS7IITvJIh2dWGwIIfpcIQhfHmyZTDQVGFT\2GvbXGgUGJFKGW6cILld5Nm\CCrbjDDU3MyKGOnbHzzJINwNWW6cILld5NqdmdiR1HMOEBjgSC|Y3nueIltdGG2aX;uJJBzd3irbXn0fUBie3OjeR?= MXWyNlA4ODZyNB?=
MG-63 cells NHmyOWpHfW6ldHnvckBie3OjeR?= MnnXNlQhcHK| NXTvNnVPVW:mdXzheIlwdiCxZjDmeYxtNWynbnf0bEBpfW2jbjDwV2c2NW[3c3XkJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iTVetOlMh[2WubIOgZ48u\XiycnXzd4lv\yCyR2[tVFIuWFCURTDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGKjc3XkJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjBzMTFOwG0> MXKyNlczPzR2OB?=
Ac2F cells M4DONGZ2dmO2aX;uJIF{e2G7 NEnUUIwxNjFidH:gNVAh|ryP NV3zUXNuPiCqcoO= NG\pWGFC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDyZZQhSWN{RjDj[YxteyCjc4Pld5Nm\CCjczDseYNq\mW{YYPlJIFkfGm4aYT5JIF1KDBwMTD0c{AyOCC3TTDh[pRmeiB4IHjyd{BjgSC{ZYDvdpRmeiCpZX7lJIF{e2G7 MYiyNlgyQTF7MB?=
293H DA cells M4rPUGZ2dmO2aX;uJIF{e2G7 NUjKZoppOTZiaB?= MWrB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBNSkRiaX6gbJVu[W5iMkmzTEBFSSClZXzsd{Bi\nSncjCxOkBpenNiYomgWHIuTlKHVDDhZ5RqfmG2aX;uJJJmeG:{dHXyJIF{e2G7LDDFR|UxRTBwMECyOEDPxE1? NWLSfoRzOjJ3OEK5O|M>
3T3L1 cells MkDlSpVv[3Srb36gZZN{[Xl? MX[xNEB2VQ>? M3jsVGlv[3KnYYPlJIlvKGGmaYDvcoVkfGmwIH3SUmEhdGW4ZXzzJIlvKFSQRnHsdIhiNWmwZIXj[YQhdW:3c3WgN3Q{VDFiY3XscJMheHKndILlZZRm\CCjdDCxNEB2VSCkZX\vdoUhXE6ILXHsdIhiKGOqYXzs[Y5o\SC{ZXzheIl3\SC2bzDjc451em:u MVqyNVg2OTB6OR?=
HepG2 cells MmezSpVv[3Srb36gZZN{[Xl? MnHtNVAhfU1? MX6yOEBp Ml;JVoVlfWO2aX;uJI9nKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbY5{fWyrbj3y[ZNqe3SjboSgbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidV2gZYZ1\XJiMkSgbJJ{KGK7IHfseYNwe2Vib4jp[IF{\SCvZYToc4QhcW5icILld4Vv[2Vib3[gNlIvOiCvTTDv[kBodHWlb4Pl MXKyN|AzPTJ2NB?=
HepG2 cells M1zJc2Z2dmO2aX;uJIF{e2G7 M4HwcVExKHWP NWDmNlZYOjRiaB?= NEDiR4tT\WS3Y4Tpc44hd2ZiZ3z1Z49{\SClb37zeY1xfGmxbjDpckBqdnO3bHnuMZJme2m|dHHueEBpfW2jbjDI[ZBIOiClZXzsd{BifCBzMDD1UUBi\nSncjCyOEBpenNiYomg[4x2[2:|ZTDvfIll[XOnIH3leIhw\CCrbjDwdoV{\W6lZTDv[kAxNjFidV2gc4YhcW6|dXzpci=> NHrCe4EzOzB{NUK0OC=>
THP1 cells MXjGeY5kfGmxbjDhd5NigQ>? NI\zS20yODBidV2= MYOzJIhzew>? MmT0WJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCqdX3hckBVUFBzIHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJGxRWy2rbnT1Z4VlKE2FUEGgcXJPSSCneIDy[ZN{cW:wIHH0JFExOCC3TTDwdoVqdmO3YnH0[YQh\m:{IEOgbJJ{KHC{aX;yJJRwKEySUzDjbIFtdGWwZ3WgcYVie3W{ZXSgZYZ1\XJiMUigbJJ{KGK7IGLUMXBEWiCjbnHsfZNqeyC{ZXzheIl3\SC2bzD1cpRz\WG2ZXSgZ49vfHKxbB?= NVfoU3hHOjJ7M{S1N|c>
THP1 cells MnTESpVv[3Srb36gZZN{[Xl? Mlf1NVAxKHWP NEn0OGo{KGi{cx?= MnmzWJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCqdX3hckBVUFBzIHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJGxRWy2rbnT1Z4VlKEmONjDtVm5CKGW6cILld5Nqd25iYYSgNVAxKHWPIIDy[Ylv[3WkYYTl[EBnd3JiMzDodpMheHKrb4KgeI8hVFCVIHPoZYxt\W6pZTDt[YF{fXKnZDDh[pRmeiBzODDodpMh[nliUmStVGNTKGGwYXz5d4l{KHKnbHH0bZZmKHSxIIXueJJm[XSnZDDjc451em:u MUSyNlk{PDV|Nx?=
HepG2 cells NEnFTItHfW6ldHnvckBie3OjeR?= MoHJWJJidnOjY4TpeoF1cW:wIH;mJGdCVDRvZoXz[YQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjD0doFve2[nY4Tl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yKM7:TR?= MmSxNlI6OzR3M{e=
HepG2 cells NFqxOHdHfW6ldHnvckBie3OjeR?= MX2yNEBp MkjyRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDHRWw1NW[3c3XkJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODJizszN MVyyNlA5OTl|Mh?=
BL21 DE3 cells M2fLN2Z2dmO2aX;uJIF{e2G7 MVzEbZNxdGGlZX3lcpQhd2ZiW{PIYZJwe2mpbHn0ZZpwdmViZoLvcUBPNXSncn3pcoFtKEircz30ZYdo\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hTXOlaHXybYNpcWFiY3;sbUBDVDJzIFTFN{Bk\WyuczDifUB{[2mwdHnscIF1cW:wIIDyc5hqdWm2eTDhd5NigSxiS3m9NE4xPzRizszN M4DwVFIzODhzOUOy
human L02 cells NH\BRllHfW6ldHnvckBie3OjeR?= MkDQRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEuVEKGIHX4dJJme3OnZDDpckBpfW2jbjDMNFIh[2WubIOgZ48u\XiycnXzd4lv\yCyR1yzMXNXPDBvR1HMOEBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHLhd4VlKHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkmg{txO MlO1NlMyQDZ|MEe=
HepG2 cells M4DWRmZ2dmO2aX;uJIF{e2G7 MVyyNEBp NFnFXYNVemGwc3HjeIl3[XSrb36gc4YhT0GOND3meZNm\CCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBJ\XCJMjDj[YxteyCjZoTldkAzOCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEO5JO69VQ>? M3rwUVI{OTdzMES1
HEK293 cells MlHpSpVv[3Srb36gZZN{[Xl? NH3kXZIyOCEQvF2= M3\ITHRz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghSVB{LWDQVmUh[XRiMUCgeW0h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 Mni4NlMzPzN3MUm=
HEK293 cells NYS0SpZ2TnWwY4Tpc44h[XO|YYm= MXHB[49vcXO2IHH0JIh2dWGwIGDQRXJo[W2vYTDMRmQh\XiycnXzd4VlKGmwIHj1cYFvKEiHS{K5N{Bk\WyuczDjc5Rz[W6|ZnXjeIVlKHerdHigS2FNPC2OdXOgZZN{\XO|ZXSgZZMhfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFA1KM7:TR?= NUn4VndXOjN{OE[3PFc>
HEK293 cells NWTyWHFXTnWwY4Tpc44h[XO|YYm= M2P0PFI1KGh? NVjZd5VDXHKjboPhZ5RqfmG2aX;uJI9nKEeDTESgSGJFNW[3c3XkJIh2dWGwIGDQRXJo[W2vYT3MRmQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOSEQvF2= NEXpWJYzOzJ7NEizNC=>
HEK293 cells NXfZcYFtTnWwY4Tpc44h[XO|YYm= MoPXOFghcHK| NGK5Z5BC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwfHKjboPm[YN1\WRid3n0bEBRWFKHeEStWGsudHWlIHHzd4V{e2WmIHHzJIFkfGm4YYTpc44hd2ZibIXjbYZmemG|ZTDhZ5Rqfmm2eTDt[YF{fXKnZDDh[pRmeiB2ODDodpMh[nlidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUSzMlcyKM7:TR?= NF;HW5czOzJ4NUi0OC=>
HepG2 cells NUnKdlBvTnWwY4Tpc44h[XO|YYm= MV\B[49vcXO2IHHjeIl3cXS7IHH0JGdCVDRvZoXz[YQhWFCDUnfhcY1iKCi3bnvuc5dvKG:{aXfpckkh\XiycnXzd4VlKGmwIHj1cYFvKEincFeyJINmdGy|IHL5JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjBzIN88US=> NULWT4xwOjN3MEKyNVI>
HepG2 cells MVTGeY5kfGmxbjDhd5NigQ>? NVX1TnlzSWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MYZ2e2WmIGDQRXJo[W2vYTDNOFY{SSCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODB{IN88US=> NU\wfIhFOjN3MEKyNVI>
L6 cells NF2x[Y1HfW6ldHnvckBie3OjeR?= MV2yOEBpenN? MkToTY5lfWO2aX;uJI9nKGeudXPvd4UhfXC2YXvlJIlvKHKjdDDMOkBk\WyuczDweYx{\WRid3n0bEBEOTRvZHXvfJkh\2y3Y3;z[UBi\nSncjCyOEBpenNiaX6gdJJme2WwY3Wgc4YhcW6|dXzpckwhTUN3ME20MlQ6KM7:TR?= NUnPb4FUOjN7OUK4OlI>
L6 cells MkD6SpVv[3Srb36gZZN{[Xl? MX6xOkBpenN? M1zZZ2lv[3KnYYPlJIlvKDJvW{PIYU1l\W:6eXfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{Bi\nSncjCxOkBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yCjbnHsfZNqeyxiRVO1NF01NjhizszN NES5VngzPDhzM{ezPC=>
DU145 cells NVPQS2ZyS3m2b4TvfIlkcXS7IHHzd4F6 NIPTZnk1QCCqcoO= M2DnZmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFXDOVA:OTZizszN M33YWFI1QTl4MUSz
PC3 cells M3vwOWN6fG:2b4jpZ4l1gSCjc4PhfS=> NVfNdlJkPDhiaILz M1vkOWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVIxNjNizszN M3HZdFI1QTl4MUSz
MDA-MB-231 cells MY\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M3y4dFI1KGi{cx?= M1LvXWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJG1FSS2PQj2yN|Eh[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygSWM2OD13LkKzJO69VQ>? MWeyOVI4QDJ|Nh?=
HEK293 cells NIS2fVZHfW6ldHnvckBie3OjeR?= NVvWRZlGSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wNUDPxE1? M1zkXVI2OzB3Nki4
HepG2 cells M4ewXWZ2dmO2aX;uJIF{e2G7 MkTONlAhcHK| MX7UdoFve2GldHn2ZZRqd25ib3[gVHBCWiC2cnHud4Zm[3SnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjCyNEBpenNiYomgVHBCWi2udXPp[oVz[XOnIHHzd4F6NCCHQ{WwQVEvPiEQvF2= NEnDR4MzPTR|N{OwOC=>
HEK293 cells MX7GeY5kfGmxbjDhd5NigQ>? NGHuWW0zPCCqcoO= NYXqZVAxXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMhcW6ldXLheIVlKG[xcjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6 MlvlNlU1PDJ|MkK=
HepG2 cells MXPGeY5kfGmxbjDhd5NigQ>? NUjkTohRSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LWDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHj1cYFvKEincFeyJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB|OTFOwG0> MXKyOVQ3OjJ6MR?=
HEK293 cells MXHGeY5kfGmxbjDhd5NigQ>? NG\o[GIzPCCqcoO= NHTCfnhC\2:waYP0JIFkfGm4aYT5JIF1KG2xdYPlJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwNWW6cILld5Nqdmdid3n0bEBI[Wx2IILldI9zfGW{II\lZ5RweiCjZoTldkAzPCCqcoOgZpkh\HWjbD3seYNq\mW{YYPlJJJmeG:{dHXyJIF{e2G7LDDFR|UxRTBwMEOg{txO Mn3QNlQ6PTV6OEm=
HepG2 cells MXjGeY5kfGmxbjDhd5NigQ>? M{jIVFIxKGi{cx?= M3\2fWFod26rc4SgZYN1cX[rdImgZZQhT0GOND3EUmEh[mmwZHnu[{Bld22jaX6g[pV{\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[XO|ZYPz[YQh[XNicnXj[ZB1d3JidILhcpNi[3SrdnH0bY9vKGmwY4XiZZRm\CCob4KgNlAhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB2IN88US=> M4jBUFI2PDl5MUOy
HepaR cells MWPGeY5kfGmxbjDhd5NigQ>? MVWxJIRigQ>? MXjB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCqdX3hckBJ\XCjUjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBJVUeFU{Kg[4Vv\SCneIDy[ZN{cW:wIHH0JFEhfU1iaX7jeYJifGWmIH\vdkAyKGSjeTDifUByfWGwdHn0ZZRqfmViUFPSJI1mfGixZDDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> Mn3ONlU1QTdzM{K=
HepaR cells MkP5SpVv[3Srb36gZZN{[Xl? M1zyeFEhfU1? Ml\aNUBl[Xl? NYHXPXFxSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiaX6gbJVu[W5iSHXwZXIh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iQV7HVHRNPCCpZX7lJIV5eHKnc4Ppc44h[XRiMTD1UUBqdmO3YnH0[YQh\m:{IEGg[IF6KGK7IIH1ZY51cXSjdHn2[UBRS1JibXX0bI9lKHKnbHH0bZZmKHSxIIXueJJm[XSnZDDjc451em:u NFG3XIEzPTR7N{GzNi=>
HepaR cells MkH2SpVv[3Srb36gZZN{[Xl? NIWzbWwyKHWP MoDhNUBl[Xl? MV7B[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCqdX3hckBJ\XCjUjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBHSUKSMTDn[Y5mKGW6cILld5Nqd25iYYSgNUB2VSCrbnP1ZoF1\WRiZn;yJFEh\GG7IHL5JJF2[W62aYTheIl3\SCSQ2KgcYV1cG:mIILlcIF1cX[nIITvJJVvfHKnYYTl[EBkd262cn;s M3LJ[VI2PDl5MUOy
HEK293 cells Mm[4SpVv[3Srb36gZZN{[Xl? Ml3GNVAh|ryP MkTNNlQhcHK| M2HDcHRz[W6|YXP0bZZifGmxbjDv[kBRWEGULXfhcY1iKCi3bnvuc5dvKG:{aXfpckkh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BifCBzMDD1UUBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6 NFG1c|MzPDh7MEC5NC=>
C2C12 cells MV7GeY5kfGmxbjDhd5NigQ>? NXXaTWRiOzBizszN M2[4bVIhcA>? Mly4TY5lfWO2aX;uJI9nKDJvZHXvfJkuYzOKXT3ncJVkd3OnIIXweIFs\SCrbjDtc5V{\SCFMlOxNkBk\WyuczDheEA{OCC3TTDh[pRmeiB{IHjyd{BjgSCuaYH1bYQhe2OrboTpcIxifGmxbjDjc5VvfGmwZzDhcoFtgXOrcx?= MYOyOVg{PTV|Nx?=
MCF7 cells M2HTbWZ2dmO2aX;uJIF{e2G7 MYSxOkBp M1;CZ2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJJRz[W6|ZnXjeIVlKGmwIHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhOTZiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC4O{DPxE1? NV\pdYk3OjZ{Mk[0PVA>
HEK293 cells MnjySpVv[3Srb36gZZN{[Xl? NXPaeJNoOTBizszN MXiyOEBp NV3Pc5pSSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiKIXub45wf25ib4Lp[4lvMSCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCjdDCxNEB2VSCrbnP1ZoF1\WRiZn;yJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? MonhNlY{QDR{OE[=

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products0

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID